Cyberkinetics' BrainGate Neural Interface System Featured in Multiple Presentations at 2007 IEEE Conference on Neural Engineering in Hawaii

Business Wire, May 7, 2007

FOXBOROUGH, Mass. -- Cyberkinetics Neurotechnology Systems, Inc. (OTCBB: CYKN; "Cyberkinetics"; "Company") announced that scientific findings from its ongoing pilot trials of the BrainGate Neural Interface System (BrainGate System) and collaborative research at Brown University were presented at the 2007 Institute of Electrical and Electronics Engineers Conference (IEEE) in Hawaii. The BrainGate System is an investigative device designed to provide communication and control of a computer, assistive devices, and, ultimately, limb movement for people who are severely disabled as a result of spinal cord injuries, strokes or ALS. The IEEE Conference highlights advances in the field of Neural Engineering that unite engineering, physics, chemistry, mathematics and computer science with molecular, cellular, cognitive and behavioral neuroscience, and encompass such areas as replacing or restoring lost sensory and motor abilities.

"Each of the advances reported in these studies is directed toward enabling a paralyzed person to someday achieve real-time, fluid control of external devices, prosthetic limbs and a person's own limbs," stated Dr. Donoghue, Cyberkinetics' Chief Scientific Officer, as well as the Henry Merritt Wriston Professor and Director of the Brain Science Program at Brown University. "With each step, we gain a stronger foothold on - literally - putting this technology into the hands of the people that need it to achieve greater independence in their lives."

"These presentations highlight the important leadership position that we have developed in the neural interface arena as a result of our progress on BrainGate." added Timothy R. Surgenor, Cyberkinetics' President and Chief Executive Officer. "Our collaboration with leading researchers Brown University has enabled us to achieve greater progress at a faster pace."

Three presentations on Saturday, May 5, 2007, by engineers from the Company and collaborators at Brown University highlighted advances in Cyberkinetics' BrainGate Neural Interface System included:

* "Multi-State Decoding of Point-and-Click Control Signals from Motor Cortical Activity in a Human with tetraplegia." Authors include Sung-Phil Kim; John Simeral; Leigh Hochberg (VA/ Harvard Medical School); John Donoghue; Gerhard Friehs; and Michael J. Black. All authors are affiliated with Brown University. This presentation described the development of "point and click" computer cursor control, which would be necessary to control medical and other devices, including wheelchairs;

* "Decoding Grasp Aperture from Motor-Cortical Population Activity." Authors include Panagiotis Artemiadis of the National Technical University of Athens; as well as Gregory Shakhnarovich; Carlos Vargas-Irwin; John Donoghue; and Michael J. Black, all of Brown University. This presentation described decoding neural activity to achieve "continuous motion", which would be important in the ability to provide more natural control of a person's own arm and hand movement, as well as prosthetic limbs; and

* "Automatic Spike Sorting for Real-Time Applications." Authors are Daniel Sebald, a consultant to Cyberkinetics, and Almut Branner, of Cyberkinetics. This presentation described automatic sorting of brain signals, which significantly reduces the time between a person's thought about movement and the ability to put the thought into action, which is aimed at providing "real-time" performance.

About Cyberkinetics Neurotechnology Systems, Inc.

Cyberkinetics Neurotechnology Systems, Inc., a leader in the neurotechnology industry, is developing neural stimulation, sensing and processing technology to improve the lives of those with severe paralysis resulting from spinal cord injuries, neurological disorders and other conditions of the nervous system. Cyberkinetics' product development pipeline includes: Andara[TM] OFS[TM] Therapy for acute spinal cord injury, an investigative device designed to stimulate nerve repair and restore sensation and motor function; the BrainGate System, an investigative device designed to provide communication and control of a computer, assistive devices, and, ultimately, limb movement; and a pilot program in the detection and prediction of seizures due to Epilepsy. Additional information is available at Cyberkinetics' website at http://www.cyberkineticsinc.com.

Forward-Looking Statements This announcement contains forward-looking statements, including statements about Cyberkinetics' product development plans and progress. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, and can be identified by the use of forward-looking terminology such as "may," "will," "believe," "expect," "anticipate" or other comparable terminology. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected in forward-looking statements and reported results shall not be considered an indication of our future performance. Factors that might cause or contribute to such differences include our limited operating history; our lack of profits from operations; our ability to successfully develop and commercialize our proposed products; a lengthy approval process and the uncertainty of FDA and other governmental regulatory requirements; clinical trials may fail to demonstrate the safety and effectiveness of our products; the degree and nature of our competition; our ability to employ and retain qualified employees; compliance with recent legislation regarding corporate governance, including the Sarbanes-Oxley Act of 2002; as well as those risks more fully discussed in our public filings with the Securities and Exchange Commission, all of which are difficult to predict and some of which are beyond our control.